Glaukos has introduced the iStent inject W, the next generation of the company’s trabecular microbypass technology for the treatment of glaucoma and an improvement over the current iStent inject. iStent inject W will supersede the current iStent inject and build upon the foundation of 2-stent trabecular microbypass technology. Featuring a wider stent flange, the new iStent inject system is designed to optimize stent visualization while maintaining a microscale footprint. Added benefits include streamlined implantation and procedural predictability. The surgical procedure and instructions for use remain the same as those for iStent inject, so no new training will be required for previously certified users.